Cover ImageSALE
市場調查報告書

免疫血液學的全球市場:2016∼2020年

Global Immunohematology Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 373450
出版日期 內容資訊 英文 99 Pages
訂單完成後即時交付
價格
Back to Top
免疫血液學的全球市場:2016∼2020年 Global Immunohematology Market 2016-2020
出版日期: 2016年09月28日 內容資訊: 英文 99 Pages
簡介

免疫血液學又稱為血液銀行,用於血中的抗原,RH因子,血漿,白血球等的檢驗,有助於削減HIV和地中海型貧血等輸血相關疾病。全球免疫血液學市場,預計2016∼2020年以4.79%的年複合成長率擴大。

本報告提供全球免疫血液學市場相關調查,市場現狀及成長預測,市場規模,各產品,各用途市場區隔,及主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 免疫血液學的全球市場:各產品市場區隔

  • 分析儀及系統
  • 試劑

第7章 免疫血液學的全球市場:各用途市場市場區隔

  • 血液相關疾病
  • HIV
  • 肝炎

第8章 免疫血液學的全球市場:各終端用戶市場區隔

  • 醫院
  • 血庫
  • 診斷測試所

第9章 免疫血液學的全球市場:各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第10章 免疫血液學的全球市場:促進要素

  • 對自動免疫血液學分析儀的終端用戶的模式轉移
  • 血庫的需求增加和銷售額增加的可能性
  • 服務導向銷售機關與透過GPO的銷售增加

第11章 促進要素的影響

第12章 免疫血液學的全球市場:課題

  • 維修成本高和血液組成的償付低
  • 捐血者的減少和降低免疫血液學分析儀銷售額的醫療指南
  • 血液檢驗和輸血的運用上的課題

第13章 促進要素與課題的影響

第14章 免疫血液學的全球市場:趨勢

第15章 供應商環境

  • 競爭趨勢
  • 各地區趨勢:主要供應商分析
  • 市場佔有率分析
  • Bio-Rad Laboratories
  • Grifols
  • Immucor
  • Ortho Clinical Diagnostics
  • 其他值得注意的供應商

第16章 附錄

第17章 關於Technavio

目錄
Product Code: IRTNTR10548

About Immunohematology

Blood loss or anemia can lead to chronic health problems; therefore, clinicians performs blood transfusion that can help to get relief from chronic health problems. To transfuse, blood clinicians or hospitals take blood units present in their own integrated blood banks or from other centers. Immunohematology, also commonly known as blood banking, helps to screen the donor blood components for blood antigens, Rh factor, plasma, and white blood cell components. It helps to reduce blood transfusion-related diseases such as HIV and thalassemia. According to the guidelines by World Health Organization (WHO), donated blood is screened before it is transfused to protect the people from such fatalities in most of the countries.

Technavio's analysts forecast the global immunohematology market to grow at a CAGR of 4.79% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global immunohematology market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various immunohematology analyzers, systems, and reagents, which are used for transfusion medicine in blood banks and hospitals to screen the blood for molecular typing and serological test.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Immunohematology Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Bio-Rad Laboratories
  • Grifols
  • Immucor
  • Ortho Clinical Diagnostics

Other Prominent Vendors

  • Agena Bioscience
  • BD
  • Beckman Coulter
  • biosurfit SA
  • Cardinal Health
  • DIAGAST
  • Hemo bioscience
  • Institut de Biotechnologies Jacques Boy
  • Lorne Laboratories
  • MTC INVITRO
  • Reagens
  • Seqirus
  • Tulip
  • Quotient

Market driver

  • Growing demand for blood banks and its potential to increase sales
  • For a full, detailed list, view our report

Market challenge

  • High maintenance cost and less reimbursement of blood components
  • For a full, detailed list, view our report

Market trend

  • Paradigm shift toward molecular immunohematology
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Serologic test and its limitation

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Global immunohematology market by analyzers and systems
  • Global immunohematology market by reagents

PART 07: Market segmentation by applications

  • Blood-related diseases
  • HIV
  • Hepatitis
  • PART 08: Market segmentation by end-users
  • Hospitals
  • Blood banks
  • Diagnostic laboratories

PART 09: Geographical segmentation

  • Immunohematology market in Americas
  • Immunohematology market in EMEA
  • Immunohematology market in APAC

PART 10: Market drivers

  • Paradigm shift of end-users toward automated immunohematology analyzer
  • Growing demand for blood banks and its potential to increase sales
  • Increasing sales through service-oriented sales organizations and GPOs

PART 11: Impact of drivers

PART 12: Market challenges

  • High maintenance cost and less reimbursement of blood components
  • Decrease in blood donors and medical guidelines reducing the sales of immunohematology analyzers
  • Operational challenge in blood screening and transfusion

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Increasing public and private funding to establish blood banks
  • Paradigm shift toward molecular immunohematology
  • Striving market growth through education and training program

PART 15: Vendor landscape

  • Competitive landscape analysis
  • Geographic presence: Key vendor analysis
  • Market share analysis
  • Bio-Rad Laboratories
  • Grifols
  • Immucor
  • Ortho Clinical Diagnostics
  • Other prominent vendors

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Blood collection and transfusion by hospital services in US 2014
  • Exhibit 03: Accredited cord blood bank of AABB in various countries
  • Exhibit 04: Market overview: Global immunohematology market
  • Exhibit 05: Impact assessment of global immunohematology market 2015
  • Exhibit 06: Global immunohematology market 2015-2020 ($ billions)
  • Exhibit 07: Blood products sold in Finland in 2012-2014
  • Exhibit 08: Global immunohematology market scenarios: Revenue forecast 2015 and 2020 ($ billions)
  • Exhibit 09: Five forces analysis
  • Exhibit 10: Global immunohematology market by product 2015 and 2020 ($ millions)
  • Exhibit 11: Market overview: Global immunohematology market by analyzers and system
  • Exhibit 12: Immunohematology analyzer and system market in 2015-2020 ($ billions)
  • Exhibit 13: Market overview: Global immunohematology market by reagents
  • Exhibit 14: Immunohematology reagents market in 2015-2020 ($ millions)
  • Exhibit 15: Prevalence of cord blood transplantation for cancerous and non-cancerous blood diseases in 2014
  • Exhibit 16: Market overview: Blood-related diseases in global immunohematology market
  • Exhibit 17: Market overview: HIV in global immunohematology market
  • Exhibit 18: Global immunohematology market by end-users 2015
  • Exhibit 19: Americas: Country-specific market impact by hospitals
  • Exhibit 20: EMEA: Country-specific market impact by hospitals
  • Exhibit 21: APAC: Country-specific market impact by hospitals
  • Exhibit 22: Americas: Country-specific market impact by blood banks
  • Exhibit 23: EMEA: Country-specific market impact by blood banks
  • Exhibit 24: APAC: Country-specific market impact by blood banks
  • Exhibit 25: Transfusion of blood in different medical segments and their usage percentage in Singapore 2016
  • Exhibit 26: Global immunohematology market by geographical segmentation: 2015 and 2020 ($ millions)
  • Exhibit 27: Geographical segmentation of global immunohematology market by market share 2015-2020
  • Exhibit 28: Americas: Market overview of immunohematology
  • Exhibit 29: Americas: Prevalence of blood-borne infections 2013-2014
  • Exhibit 30: Immunohematology market in Americas 2015-2020 ($ millions)
  • Exhibit 31: Immunohematology market in Americas: Metric analysis for various countries
  • Exhibit 32: Key takeaway: Immunohematology market in US
  • Exhibit 33: EMEA: Market overview of immunohematology
  • Exhibit 34: Number of blood transfusions performed in Europe in 2014 (millions)
  • Exhibit 35: Immunohematology market in Europe 2015-2020 ($ millions)
  • Exhibit 36: Immunohematology market in EMEA: Metric analysis for various countries
  • Exhibit 37: Key takeaway: Immunohematology market in UK
  • Exhibit 38: APAC: Market overview of immunohematology
  • Exhibit 39: Immunohematology market in APAC 2015-2020 ($ millions)
  • Exhibit 40: Immunohematology market in APAC: Metric analysis for various countries
  • Exhibit 41: Key takeaway: Immunohematology market in China
  • Exhibit 42: Market impact: Fully automated immunohematology analyzer based on end-users
  • Exhibit 43: Potential market revenue of immunohematology with estimated number of cord blood units sold worldwide
  • Exhibit 44: Sales strategies of distributors and companies
  • Exhibit 45: Impact of drivers
  • Exhibit 46: Cost of cord blood unit maintenance in private and public blood banks
  • Exhibit 47: Impact of drivers and challenges
  • Exhibit 48: Blood banks: Public-private partnership
  • Exhibit 49: Blood banks: Market impact
  • Exhibit 50: Companies focusing on immunohematology training to promote marketing and sales
  • Exhibit 51: Competitive structure analysis of global immunohematology market 2015
  • Exhibit 52: Competitive landscape analysis of global immunohematology market 2015
  • Exhibit 53: Global immunohematology market: Market share analysis of vendors 2015
  • Exhibit 54: Bio-Rad Laboratories: Profile summary
  • Exhibit 55: Bio-Rad Laboratories: Strength analysis
  • Exhibit 56: Bio-Rad Laboratories: Growth strategy matrix
  • Exhibit 57: Bio-Rad Laboratories: Opportunity assessment
  • Exhibit 58: Grifols: Profile summary
  • Exhibit 59: Grifols: Strength analysis
  • Exhibit 60: Grifols: Growth strategy matrix
  • Exhibit 61: Grifols: Opportunity assessment
  • Exhibit 62: Immucor: Profile summary
  • Exhibit 63: Immucor: Strength analysis
  • Exhibit 64: Immucor: Growth strategy matrix
  • Exhibit 65: Immucor: Opportunity assessment
  • Exhibit 66: Ortho Clinical Diagnostics: Profile summary
  • Exhibit 67: Ortho Clinical Diagnostics: Strength analysis
  • Exhibit 68: Ortho Clinical Diagnostics: Growth strategy matrix
  • Exhibit 69: Ortho Clinical Diagnostics: Opportunity assessment
  • Exhibit 70: Other prominent vendors
Back to Top